Medpace Holdings (MEDP) Shares Outstanding (Diluted Average) (2020 - 2025)
Medpace Holdings' Shares Outstanding (Diluted Average) history spans 6 years, with the latest figure at $29.5 million for Q4 2025.
- For Q4 2025, Shares Outstanding (Diluted Average) fell 7.77% year-over-year to $29.5 million; the TTM value through Dec 2025 reached $29.5 million, down 7.77%, while the annual FY2025 figure was $29.5 million, 7.77% down from the prior year.
- Shares Outstanding (Diluted Average) reached $29.5 million in Q4 2025 per MEDP's latest filing, up from $28.8 million in the prior quarter.
- In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $37.7 million in Q4 2021 to a low of $28.8 million in Q3 2025.
- Average Shares Outstanding (Diluted Average) over 5 years is $32.6 million, with a median of $32.0 million recorded in 2024.
- Peak YoY movement for Shares Outstanding (Diluted Average): fell 14.31% in 2022, then grew 0.94% in 2024.
- A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $37.7 million in 2021, then fell by 10.68% to $33.7 million in 2022, then fell by 5.43% to $31.8 million in 2023, then increased by 0.54% to $32.0 million in 2024, then decreased by 7.77% to $29.5 million in 2025.
- Per Business Quant, the three most recent readings for MEDP's Shares Outstanding (Diluted Average) are $29.5 million (Q4 2025), $28.8 million (Q3 2025), and $30.2 million (Q2 2025).